NCT06795503 2025-01-28Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer PatientsFudan UniversityPhase 3 Not yet recruiting1,462 enrolled
NCT04301739 2020-03-12to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)Shanghai Henlius BiotechPhase 3 Not yet recruiting522 enrolled